These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 8783387)
1. Effects of diltiazem, a Ca2+ channel blocker, on naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats. Tokuyama S; Ho IK Psychopharmacology (Berl); 1996 May; 125(2):135-40. PubMed ID: 8783387 [TBL] [Abstract][Full Text] [Related]
2. A protein kinase inhibitor, H-7, blocks naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats. Tokuyama S; Ho IK; Yamamoto T Brain Res Bull; 2000 Jul; 52(5):363-9. PubMed ID: 10922515 [TBL] [Abstract][Full Text] [Related]
3. Ca2+ channel blocker, diltiazem, prevents physical dependence and the enhancement of protein kinase C activity by opioid infusion in rats. Tokuyama S; Feng Y; Wakabayashi H; Ho IK Eur J Pharmacol; 1995 Jun; 279(1):93-8. PubMed ID: 7556388 [TBL] [Abstract][Full Text] [Related]
4. Naloxone-precipitated changes in biogenic amines and their metabolites in various brain regions of butorphanol-dependent rats. Tokuyama S; Wakabayashi H; Hoskins B; Ho IK Pharmacol Biochem Behav; 1996 Jun; 54(2):461-8. PubMed ID: 8743609 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of diltiazem, an L-type Ca2+ channel blocker, on naloxone-increased glutamate levels in the locus coeruleus of opioid-dependent rats. Tokuyama S; Ho IK Brain Res; 1996 May; 722(1-2):212-6. PubMed ID: 8813371 [TBL] [Abstract][Full Text] [Related]
6. Simultaneous measurement of biogenic amines and their metabolites in rat brain regions after acute administration of and abrupt withdrawal from butorphanol or morphine. Wakabayashi H; Tokuyama S; Ho IK Neurochem Res; 1995 Oct; 20(10):1179-85. PubMed ID: 8746803 [TBL] [Abstract][Full Text] [Related]
7. Changes in the brain kappa-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol. Fan LW; Tien LT; Tanaka S; Ma T; Chudapongse N; Sinchaisuk S; Rockhold RW; Ho IK Neuroscience; 2003; 121(4):1063-74. PubMed ID: 14580956 [TBL] [Abstract][Full Text] [Related]
8. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis. Sinchaisuk S; Ho IK; Rockhold RW Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173 [TBL] [Abstract][Full Text] [Related]
10. Mu- and delta-opioid receptor antagonists precipitate similar withdrawal phenomena in butorphanol and morphine dependence. Feng YZ; Zhang T; Tokuyama S; Zhu H; Rockhold RW; Ho IK Neurochem Res; 1996 Jan; 21(1):63-71. PubMed ID: 8833225 [TBL] [Abstract][Full Text] [Related]
11. Withdrawal from dependence upon butorphanol uniquely increases kappa(1)-opioid receptor binding in the rat brain. Fan LW; Tanaka S; Tien LT; Ma T; Rockhold RW; Ho IK Brain Res Bull; 2002 Jun; 58(2):149-60. PubMed ID: 12127012 [TBL] [Abstract][Full Text] [Related]
12. Possible involvement of protein kinases in physical dependence on opioids: studies using protein kinase inhibitors, H-7 and H-8. Tokuyama S; Feng Y; Wakabayashi H; Ho IK Eur J Pharmacol; 1995 Sep; 284(1-2):101-7. PubMed ID: 8549612 [TBL] [Abstract][Full Text] [Related]
13. Involvement of mu- and delta-opioid receptors in the effects of systemic and locally perfused morphine on extracellular levels of dopamine, DOPAC and HVA in the nucleus accumbens of the halothane-anaesthetized rat. Borg PJ; Taylor DA Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):582-8. PubMed ID: 9151296 [TBL] [Abstract][Full Text] [Related]
14. The role of glutamate in the locus coeruleus during opioid withdrawal and effects of H-7, a protein kinase inhibitor, on the action of glutamate in rats. Tokuyama S; Zhu H; Wakabayashi H; Feng YZ; Ho IK J Biomed Sci; 1998; 5(1):45-53. PubMed ID: 9570513 [TBL] [Abstract][Full Text] [Related]
15. Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal. Chartoff EH; Mague SD; Barhight MF; Smith AM; Carlezon WA J Neurosci; 2006 Jun; 26(24):6450-7. PubMed ID: 16775132 [TBL] [Abstract][Full Text] [Related]
16. Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome. Tokuyama S; Wakabayashi H; Ho IK Eur J Pharmacol; 1996 Jan; 295(2-3):123-9. PubMed ID: 8720575 [TBL] [Abstract][Full Text] [Related]
17. Dopamine-dependent increases in phosphorylation of cAMP response element binding protein (CREB) during precipitated morphine withdrawal in primary cultures of rat striatum. Chartoff EH; Papadopoulou M; Konradi C; Carlezon WA J Neurochem; 2003 Oct; 87(1):107-18. PubMed ID: 12969258 [TBL] [Abstract][Full Text] [Related]
18. Baclofen reestablishes striatal and cortical dopamine concentrations during naloxone-precipitated withdrawal. Diaz SL; Kemmling AK; Balerio GN Neurochem Int; 2003 Mar; 42(4):293-8. PubMed ID: 12470702 [TBL] [Abstract][Full Text] [Related]
19. Involvement of kappa-opioid receptors in opioid dependence/withdrawal: studies using butorphanol. Jaw SP; Makimura M; Oh KW; Hoskins B; Ho IK Eur J Pharmacol; 1994 May; 257(1-2):153-60. PubMed ID: 8082697 [TBL] [Abstract][Full Text] [Related]
20. Further evidence for a role of NMDA receptors in the locus coeruleus in the expression of withdrawal syndrome from opioids. Tokuyama S; Zhu H; Oh S; Ho IK; Yamamoto T Neurochem Int; 2001 Aug; 39(2):103-9. PubMed ID: 11408088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]